Urologix, Inc. Stock
Stocks
ULGX
US9172731047
Mining Support Services & Equipment
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -.--% |
|
-.--% | - |
| 02/02/16 | A unknown buyer acquired substantially all of the operating assets of Urologix, Inc. | CI |
| 09/07/15 | Urologix Conducting A Strategic Review | CI |
| Market Cap | 2.13M 1.85M 1.73M 1.58M 2.98M 202M 3.03M 20.23M 7.94M 101M 7.99M 7.82M 337M | P/E 2013 |
-0.8x | P/E 2014 | -0.49x |
|---|---|---|---|---|---|
| Enterprise Value | 6.74M 5.85M 5.48M 5.02M 9.45M 641M 9.6M 64.11M 25.17M 321M 25.31M 24.77M 1.07B | EV / Sales 2013 |
0.4x | EV / Sales 2014 | 0.59x |
| Free-Float |
100% | Yield 2013 * |
-
| Yield 2014 | - |
| 1 month | 0 | 0 | |
| Current year | 0 | 0.02 | |
| 1 year | 0 | 0.03 | |
| 3 years | 0 | 0.04 | |
| 5 years | 0 | 0.04 | |
| 10 years | 0 | 0.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Madson
DFI | Director of Finance/CFO | 65 | 01/04/2015 |
Lisa Ackermann
SAM | Sales & Marketing | 53 | 16/06/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Mitchell Dann
CHM | Chairman | 65 | 29/05/1991 |
Sidney Emery
BRD | Director/Board Member | 76 | 03/10/2005 |
| Director/Board Member | 59 | 06/08/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | -.--% | -.--% | 2.13K | ||
| -2.35% | +0.07% | -23.78% | +5.77% | 3.18B | ||
| +7.89% | +11.41% | +47.27% | +1,285.14% | 2.67B | ||
| +10.01% | +72.23% | +4.74% | +330.42% | 1.84B | ||
| +0.53% | +1.60% | -32.70% | -18.96% | 1.74B | ||
| -1.90% | +13.81% | +232.26% | +564.52% | 1.58B | ||
| -2.96% | +2.61% | +15.91% | +20.16% | 500M | ||
| +1.41% | +11.34% | +15.14% | +24.14% | 324M | ||
| +5.79% | +24.55% | +71.25% | +50.55% | 181M | ||
| -4.32% | -0.75% | +33.00% | +129.31% | 120M | ||
| Average | +1.41% | +10.15% | +36.31% | +239.10% | 1.21B | |
| Weighted average by Cap. | +2.42% | +10.97% | +32.87% | +408.58% |
| 2013 | 2014 | |
|---|---|---|
| Net sales | 16.48M 14.31M 13.39M 12.26M 23.1M 1.57B 23.46M 157M 61.53M 785M 61.87M 60.54M 2.61B | 14.01M 12.16M 11.38M 10.42M 19.63M 1.33B 19.94M 133M 52.3M 667M 52.59M 51.46M 2.22B |
| Net income | -4.29M -3.73M -3.49M -3.19M -6.01M -408M -6.11M -40.81M -16.02M -204M -16.11M -15.76M -680M | -7.61M -6.6M -6.18M -5.66M -10.66M -724M -10.83M -72.33M -28.4M -362M -28.56M -27.94M -1.21B |
| Net Debt | 3.04M 2.64M 2.47M 2.26M 4.26M 289M 4.33M 28.93M 11.36M 145M 11.42M 11.18M 482M | 4.62M 4.01M 3.75M 3.43M 6.47M 439M 6.57M 43.88M 17.23M 220M 17.32M 16.95M 731M |
Employees
61
- Stock Market
- Stocks
- ULGX Stock
Select your edition
All financial news and data tailored to specific country editions
















